CardioGen-82 (Bracco Diagnostics Inc)


Welcome to the PulseAid listing for the CardioGen-82 drug offered from Bracco Diagnostics Inc. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bracco Diagnostics Inc
NON-PROPRIETARY NAME: Rubidium Chloride RB-82
SUBSTANCE NAME: RUBIDIUM CHLORIDE RB-82
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1989-12-30
END MARKETING DATE: 0000-00-00


CardioGen-82 HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCardioGen-82 from Bracco Diagnostics Inc
LABELER NAME: Bracco Diagnostics Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mCi/1)
START MARKETING DATE: 1989-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0270-0091_b51739a7-f4a7-4c3f-af96-6b75d661bf41
PRODUCT NDC: 0270-0091
APPLICATION NUMBER: NDA019414

Other RUBIDIUM CHLORIDE RB-82 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bracco Diagnostics IncCardioGen-82
Jubilant DraxImage Inc.RUBY-FILL